Latest news
Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapy - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 15:16:34 GMTBlossomHill, Latigo outshine IPO expectations with oversubscribed debuts - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 15:10:10 GMTBioMarin axes $270M asset after missing phase 3 endpoint - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 13:10:41 GMT‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 13:08:00 GMTNovo Nordisk’s CFO on the oral Wegovy rollout and beyond - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 12:42:20 GMTBioNTech brings in Sobi CEO—Chutes & Ladders - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 12:30:00 GMTTakeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:10:41 GMTPacBio CEO steps down amid layoffs, widening Q2 loss - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 14:45:21 GMT